Ifigeneia Tzannou

1.3k total citations
42 papers, 395 citations indexed

About

Ifigeneia Tzannou is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Ifigeneia Tzannou has authored 42 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 20 papers in Epidemiology and 14 papers in Immunology. Recurrent topics in Ifigeneia Tzannou's work include Polyomavirus and related diseases (14 papers), Cytomegalovirus and herpesvirus research (13 papers) and CAR-T cell therapy research (10 papers). Ifigeneia Tzannou is often cited by papers focused on Polyomavirus and related diseases (14 papers), Cytomegalovirus and herpesvirus research (13 papers) and CAR-T cell therapy research (10 papers). Ifigeneia Tzannou collaborates with scholars based in United States, Greece and Czechia. Ifigeneia Tzannou's co-authors include Ann M. Leen, Swati Naik, Premal Lulla, P. Kosmidis, Manik Kuvalekar, Juan F. Vera, N. Tsavaris, N. Mylonakis, Carlos A. Ramos and Helen E. Heslop and has published in prestigious journals such as Blood, Clinical Cancer Research and The Journal of Infectious Diseases.

In The Last Decade

Ifigeneia Tzannou

41 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ifigeneia Tzannou United States 12 220 182 76 74 73 42 395
J. Fraga Spain 15 76 0.3× 217 1.2× 73 1.0× 78 1.1× 42 0.6× 62 558
Leonardo Bugatti Italy 12 124 0.6× 162 0.9× 113 1.5× 42 0.6× 26 0.4× 33 473
Naoki Kasuga Japan 8 193 0.9× 259 1.4× 87 1.1× 86 1.2× 71 1.0× 9 428
C R Harman Australia 9 223 1.0× 74 0.4× 37 0.5× 41 0.6× 46 0.6× 11 399
Omeed Memar United States 13 237 1.1× 177 1.0× 62 0.8× 18 0.2× 90 1.2× 25 526
Amélie Osio France 10 172 0.8× 96 0.5× 32 0.4× 27 0.4× 28 0.4× 19 391
Maximiliano Aragüés Spain 13 54 0.2× 116 0.6× 39 0.5× 77 1.0× 37 0.5× 35 421
Diane M. Hoss United States 13 124 0.6× 160 0.9× 49 0.6× 50 0.7× 26 0.4× 25 487
Cengizhan Erdem Türkiye 12 173 0.8× 216 1.2× 31 0.4× 33 0.4× 34 0.5× 32 422
Hideho Henzan Japan 14 219 1.0× 100 0.5× 248 3.3× 60 0.8× 57 0.8× 36 641

Countries citing papers authored by Ifigeneia Tzannou

Since Specialization
Citations

This map shows the geographic impact of Ifigeneia Tzannou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ifigeneia Tzannou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ifigeneia Tzannou more than expected).

Fields of papers citing papers by Ifigeneia Tzannou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ifigeneia Tzannou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ifigeneia Tzannou. The network helps show where Ifigeneia Tzannou may publish in the future.

Co-authorship network of co-authors of Ifigeneia Tzannou

This figure shows the co-authorship network connecting the top 25 collaborators of Ifigeneia Tzannou. A scholar is included among the top collaborators of Ifigeneia Tzannou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ifigeneia Tzannou. Ifigeneia Tzannou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pfeiffer, Thomas, Ifigeneia Tzannou, Meng-Fen Wu, et al.. (2023). Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting. Clinical Cancer Research. 29(2). 324–330. 49 indexed citations
2.
Παπαδοπούλου, Αναστασία, et al.. (2023). Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond. HemaSphere. 7(1). e809–e809. 11 indexed citations
3.
4.
Bergamaschi, Cristina, Maria Pagoni, Margherita Rosati, et al.. (2022). Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies. Frontiers in Immunology. 13. 899972–899972. 14 indexed citations
5.
Pfeiffer, Thomas, Ifigeneia Tzannou, Swati Naik, et al.. (2021). Allogeneic, Off-the-Shelf Multi-Virus Specific T-Lymphocytes for the Treatment of Virus-Associated Hemorrhagic Cystitis in the Post-HSCT Setting. Transplantation and Cellular Therapy. 27(3). S91–S92. 1 indexed citations
6.
Vasileiou, Spyridoula, Manik Kuvalekar, Ayumi Watanabe, et al.. (2019). Rapid Generation of Multivirus-Specific T Lymphocytes for the Prevention and Treatment of Respiratory Viral Infections. Biology of Blood and Marrow Transplantation. 25(3). S363–S363. 4 indexed citations
7.
Arasaratnam, Reuben J., Ifigeneia Tzannou, Paibel Aguayo‐Hiraldo, et al.. (2018). Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients. American Journal of Transplantation. 18(9). 2238–2249. 8 indexed citations
8.
Tzannou, Ifigeneia, et al.. (2018). Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients. Current Opinion in Infectious Diseases. 31(4). 292–300. 19 indexed citations
9.
Lulla, Premal, Swati Naik, Ifigeneia Tzannou, et al.. (2017). Safety and Efficacy of Adoptively Transferred Donor-Derived Tumor-Directed T Cells with Relapsed AML Post-Allogeneic HSCT. Blood. 130. 164–164. 1 indexed citations
10.
Tzannou, Ifigeneia, Kathryn Leung, Caridad Martinez, et al.. (2016). Safety and Preliminary Efficacy of "Ready to Administer" Cytomegalovirus (CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection. Blood. 128(22). 388–388. 1 indexed citations
11.
Omer, Bilal, Αναστασία Παπαδοπούλου, Adrian P. Gee, et al.. (2015). Administration of Most Closely HLA-Matched Multivirus-Specific T Cells for the Treatment of EBV, CMV, AdV, HHV6, and BKV Post Allogeneic Hematopoietic Stem Cell Transplant. Blood. 126(23). 622–622. 2 indexed citations
12.
Tzannou, Ifigeneia & Ann M. Leen. (2015). Preventing Stem Cell Transplantation-Associated Viral Infections Using T-Cell Therapy. Immunotherapy. 7(7). 793–810. 11 indexed citations
13.
Παπαδοπούλου, Αναστασία, Usha L. Katari, Ulrike Gerdemann, et al.. (2014). Safety and clinical efficacy of rapidly-generated virus-specific T cells with activity against adv, EBV, CMV, HHV6 and BK virus administered after allogeneic hematopoietic stem cell transplant. Cytotherapy. 16(4). S7–S7. 1 indexed citations
14.
Matikas, Alexios, et al.. (2013). Primary abdominal muscle lymphoma. BMJ Case Reports. 2013. bcr2012008311–bcr2012008311. 5 indexed citations
15.
Matikas, Alexios, et al.. (2013). Primary Bone Lymphoma: A Retrospective Analysis of 22 Patients Treated in a Single Tertiary Center. Acta Haematologica. 130(4). 291–296. 12 indexed citations
16.
Tzannou, Ifigeneia, et al.. (2011). Hemophagocytic Syndrome Associated with Hematologic Malignancies. 6(3). 110–117. 3 indexed citations
17.
Tsavaris, N., et al.. (1992). Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach. Cancer Chemotherapy and Pharmacology. 30(4). 330–333. 40 indexed citations
18.
Tsavaris, Νicolas, et al.. (1992). Continuous 24-Hour Infusion of Folinic Acid Does Not Increase the Response Rate of 5-Fluorouracil but Only the Toxicity. Oncology. 49(2). 154–156. 1 indexed citations
19.
Tsavaris, N., et al.. (1990). Comparison of Antiemetic Activity of Chloropromazine and High Doses of Metoclopramide in Cisplatin-Based Chemotherapy. Acta Oncologica. 29(8). 1005–1009. 7 indexed citations
20.
Tsavaris, N., et al.. (1990). Conservative Approach to the Treatment of Chemotherapy‐Induced Extravasation. The Journal of Dermatologic Surgery and Oncology. 16(6). 519–522. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Fraga Breakdown of academic impact, for papers by Leonardo Bugatti Breakdown of academic impact, for papers by Naoki Kasuga Breakdown of academic impact, for papers by C R Harman Breakdown of academic impact, for papers by Omeed Memar Breakdown of academic impact, for papers by Amélie Osio Breakdown of academic impact, for papers by Maximiliano Aragüés Breakdown of academic impact, for papers by Diane M. Hoss Breakdown of academic impact, for papers by Cengizhan Erdem Breakdown of academic impact, for papers by Hideho Henzan
Rankless by CCL
2026